MORRIS PLAINS, N.J., Oct. 4 /PRNewswire/ -- Skila, A Sela2 Company, announces the launch of iperformance, the next generation of its unique solutions for performance management. Today, executive management at pharmaceutical and biotechnology companies is under pressure to enhance performance visibility, allocate resources more efficiently, and quickly respond to rapidly changing market conditions. Historically, pharmaceutical and biotechnology companies have looked at performance measurement, but in today's fast-paced global business environment simply monitoring performance is not enough. Corporate managers need proactive solutions that will enable them to manage performance and not just measure it.

iperformance has been designed to enable managers to use predictive information to optimize results and alert managers to trends that affect their business objectives. By investing in Skila's iperformance solution, executive managers are able to drill down into specific issues, understand root causes and make decisions based on data that is connected to corporate objectives and has strategic context. Planned to meet real business needs and expectations of the pharmaceutical and life sciences industry, iperformance connects strategy with execution.

With critical data scattered horizontally and vertically across a corporation, iperformance ensures alignment with the overall corporate strategy by gathering the data from multiple sources into a single touch point. More importantly, iperformance organizes and presents this data in a holistic format which allows users to quickly identify new threats and opportunities and draw conclusions more intuitively.

With iperformance, companies can now easily access and track the progress of Key Performance Indicators (KPIs) against pre-defined targets. The solution also delivers collaboration tools that encourage users to share learnings and implement Best Practices; and offers early-warning signals and real-time alerts that enable managers to quickly take appropriate corrective action. iperformance goes beyond performance measurement and delivers relevant information from multiple sources, enabling managers to make sound decisions that are directly tied to achieving corporate objectives.

"An effective performance management solution is one that enables a company to effectively address a rapidly changing market environment. Our next- generation iperformance solution has been built based on our experience with our customers and extensive client feedback. iperformance provides a powerful combination of information, collaboration and workflow tools which close the performance loop between the high-level strategies and daily execution," commented Moish Tov, CEO of Skila. "In addition, Skila incorporates best practices to provide senior management with a proven and consistent framework for tracking, understanding and managing their business performance."

Skila's solutions are presently being used in support of global brands across 56 countries, including the United States, Canada, Mexico, UK, Germany, France, Spain and Japan. Most recently, Boehringer Ingelheim has expanded its contract with Skila to implement a comprehensive suite of solutions as its Brand Resource Platform serving products in various stages across Boehringer Ingelheim's brand portfolio in prescription medicine and consumer health. With an installed base extending from Boehringer Ingelheim corporate headquarters in Ingelheim, Germany, to affiliates in numerous countries worldwide, Skila's platform will allow Boehringer Ingelheim to improve communication, increase coordination, and enhance planning and decision-making capabilities across the global organization.

About Skila

Skila is a customer driven company and a leader in developing best-in-class knowledge-driven management solutions for the pharmaceutical industry. Skila's solutions help the pharmaceutical industry increase their marketing and brand effectiveness and have been adopted by many of the leading companies in the industry, such as: Boehringer Ingelheim, Roche, Eli Lilly & Company, Allergan and Johnson & Johnson.

Utilizing expert services, unique methodology and its Intelligration(R) technology, Skila's solutions integrate critical information, communicating it to the right people, at the right time through a "Single Touch Point." These solutions are vital to pharmaceutical organizations in successfully managing common business challenges such as:

    -- Optimizing product launches
    -- Maximizing the impact of strategic alliances with marketing partners
    -- Effectively managing competitive intelligence for strategic advantage
    -- Maximizing share of mind with key opinion leaders
    -- Synchronizing measurement and performance of global brand teams
    -- Maximizing effectiveness between marketing, sales, and medical teams

SOURCE Skila